معالجة مناعية للسرطان (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "معالجة مناعية للسرطان" in Arabic language version.

refsWebsite

Global rank Arabic rank

13nih.gov

4^th place

6^th place

7doi.org

2^nd place

5^th place

2web.archive.org

1^st place

1cancer.gov

1,684^th place

1,025^th place

1asheducationbook.org

low place

1harvard.edu

18^th place

33^rd place

asheducationbook.org

Chronic Lymphocytic Leukemia. Hematology (Am Soc Hematol Educ Program) 2004: 163-183. Date retrieved: 26/01/2006. نسخة محفوظة 2006-12-02 في Wayback Machine

cancer.gov

"CAR T-Cell Therapy: Engineering Patients' Immune Cells to Treat Their Cancers". cancer.gov. 6 ديسمبر 2013. مؤرشف من الأصل في 2015-04-13. اطلع عليه بتاريخ 2014-05-09.

doi.org

Demko S، Summers J، Keegan P، Pazdur R (فبراير 2008). "FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia". The Oncologist. ج. 13 ع. 2: 167–74. DOI:10.1634/theoncologist.2007-0218. PMID:18305062.
Riddell SR (يوليو 2001). "Progress in cancer vaccines by enhanced self-presentation". Proceedings of the National Academy of Sciences of the United States of America. ج. 98 ع. 16: 8933–35. Bibcode:2001PNAS...98.8933R. DOI:10.1073/pnas.171326398. PMC:55350. PMID:11481463.
Palucka K، Banchereau J (يوليو 2013). "Dendritic-cell-based therapeutic cancer vaccines". Immunity. ج. 39 ع. 1: 38–48. DOI:10.1016/j.immuni.2013.07.004. PMC:3788678. PMID:23890062.
Kucerova P، Cervinkova M (أبريل 2016). "Spontaneous regression of tumour and the role of microbial infection--possibilities for cancer treatment". Anti-Cancer Drugs. ج. 27 ع. 4: 269–77. DOI:10.1097/CAD.0000000000000337. PMC:4777220. PMID:26813865.
Kienle GS (مارس 2012). "Fever in Cancer Treatment: Coley's Therapy and Epidemiologic Observations". Global Advances in Health and Medicine. ج. 1 ع. 1: 92–100. DOI:10.7453/gahmj.2012.1.1.016. PMC:3833486. PMID:24278806.
Korneev KV، Atretkhany KN، Drutskaya MS، Grivennikov SI، Kuprash DV، Nedospasov SA (يناير 2017). "TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis". Cytokine. ج. 89: 127–35. DOI:10.1016/j.cyto.2016.01.021. PMID:26854213.
Espinoza-Sánchez NA، Götte M (مايو 2020). "Role of cell surface proteoglycans in cancer immunotherapy". Seminars in Cancer Biology. ج. 62: 48–67. DOI:10.1016/j.semcancer.2019.07.012. PMID:31336150.

harvard.edu

ui.adsabs.harvard.edu

Riddell SR (يوليو 2001). "Progress in cancer vaccines by enhanced self-presentation". Proceedings of the National Academy of Sciences of the United States of America. ج. 98 ع. 16: 8933–35. Bibcode:2001PNAS...98.8933R. DOI:10.1073/pnas.171326398. PMC:55350. PMID:11481463.

nih.gov

pubmed.ncbi.nlm.nih.gov

Demko S، Summers J، Keegan P، Pazdur R (فبراير 2008). "FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia". The Oncologist. ج. 13 ع. 2: 167–74. DOI:10.1634/theoncologist.2007-0218. PMID:18305062.
Riddell SR (يوليو 2001). "Progress in cancer vaccines by enhanced self-presentation". Proceedings of the National Academy of Sciences of the United States of America. ج. 98 ع. 16: 8933–35. Bibcode:2001PNAS...98.8933R. DOI:10.1073/pnas.171326398. PMC:55350. PMID:11481463.
Palucka K، Banchereau J (يوليو 2013). "Dendritic-cell-based therapeutic cancer vaccines". Immunity. ج. 39 ع. 1: 38–48. DOI:10.1016/j.immuni.2013.07.004. PMC:3788678. PMID:23890062.
Kucerova P، Cervinkova M (أبريل 2016). "Spontaneous regression of tumour and the role of microbial infection--possibilities for cancer treatment". Anti-Cancer Drugs. ج. 27 ع. 4: 269–77. DOI:10.1097/CAD.0000000000000337. PMC:4777220. PMID:26813865.
Kienle GS (مارس 2012). "Fever in Cancer Treatment: Coley's Therapy and Epidemiologic Observations". Global Advances in Health and Medicine. ج. 1 ع. 1: 92–100. DOI:10.7453/gahmj.2012.1.1.016. PMC:3833486. PMID:24278806.
McCarthy EF (2006). "The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas". The Iowa Orthopaedic Journal. ج. 26: 154–8. PMC:1888599. PMID:16789469.
Korneev KV، Atretkhany KN، Drutskaya MS، Grivennikov SI، Kuprash DV، Nedospasov SA (يناير 2017). "TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis". Cytokine. ج. 89: 127–35. DOI:10.1016/j.cyto.2016.01.021. PMID:26854213.
Espinoza-Sánchez NA، Götte M (مايو 2020). "Role of cell surface proteoglycans in cancer immunotherapy". Seminars in Cancer Biology. ج. 62: 48–67. DOI:10.1016/j.semcancer.2019.07.012. PMID:31336150.

ncbi.nlm.nih.gov

Riddell SR (يوليو 2001). "Progress in cancer vaccines by enhanced self-presentation". Proceedings of the National Academy of Sciences of the United States of America. ج. 98 ع. 16: 8933–35. Bibcode:2001PNAS...98.8933R. DOI:10.1073/pnas.171326398. PMC:55350. PMID:11481463.
Palucka K، Banchereau J (يوليو 2013). "Dendritic-cell-based therapeutic cancer vaccines". Immunity. ج. 39 ع. 1: 38–48. DOI:10.1016/j.immuni.2013.07.004. PMC:3788678. PMID:23890062.
Kucerova P، Cervinkova M (أبريل 2016). "Spontaneous regression of tumour and the role of microbial infection--possibilities for cancer treatment". Anti-Cancer Drugs. ج. 27 ع. 4: 269–77. DOI:10.1097/CAD.0000000000000337. PMC:4777220. PMID:26813865.
Kienle GS (مارس 2012). "Fever in Cancer Treatment: Coley's Therapy and Epidemiologic Observations". Global Advances in Health and Medicine. ج. 1 ع. 1: 92–100. DOI:10.7453/gahmj.2012.1.1.016. PMC:3833486. PMID:24278806.
McCarthy EF (2006). "The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas". The Iowa Orthopaedic Journal. ج. 26: 154–8. PMC:1888599. PMID:16789469.

web.archive.org

"CAR T-Cell Therapy: Engineering Patients' Immune Cells to Treat Their Cancers". cancer.gov. 6 ديسمبر 2013. مؤرشف من الأصل في 2015-04-13. اطلع عليه بتاريخ 2014-05-09.
Chronic Lymphocytic Leukemia. Hematology (Am Soc Hematol Educ Program) 2004: 163-183. Date retrieved: 26/01/2006. نسخة محفوظة 2006-12-02 في Wayback Machine